NM_005219.5:c.402+12delG

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_005219.5(DIAPH1):​c.402+12delG variant causes a intron change. The variant allele was found at a frequency of 0.00482 in 1,554,796 control chromosomes in the GnomAD database, including 40 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0038 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0049 ( 35 hom. )

Consequence

DIAPH1
NM_005219.5 intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 3.59

Publications

1 publications found
Variant links:
Genes affected
DIAPH1 (HGNC:2876): (diaphanous related formin 1) This gene is a homolog of the Drosophila diaphanous gene, and has been linked to autosomal dominant, fully penetrant, nonsyndromic sensorineural progressive low-frequency hearing loss. Actin polymerization involves proteins known to interact with diaphanous protein in Drosophila and mouse. It has therefore been speculated that this gene may have a role in the regulation of actin polymerization in hair cells of the inner ear. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
DIAPH1 Gene-Disease associations (from GenCC):
  • DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • autosomal dominant nonsyndromic hearing loss 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • progressive microcephaly-seizures-cortical blindness-developmental delay syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 5-141584111-TC-T is Benign according to our data. Variant chr5-141584111-TC-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 163077.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00377 (574/152188) while in subpopulation AMR AF = 0.0109 (167/15278). AF 95% confidence interval is 0.00958. There are 5 homozygotes in GnomAd4. There are 277 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIAPH1NM_005219.5 linkc.402+12delG intron_variant Intron 4 of 27 ENST00000389054.8 NP_005210.3 O60610-1Q6URC4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIAPH1ENST00000389054.8 linkc.402+12delG intron_variant Intron 4 of 27 5 NM_005219.5 ENSP00000373706.4 O60610-1
DIAPH1ENST00000518047.5 linkc.375+12delG intron_variant Intron 3 of 26 5 ENSP00000428268.2 O60610-3
DIAPH1ENST00000647433.1 linkc.402+12delG intron_variant Intron 4 of 28 ENSP00000494675.1 A0A2R8Y5N1
DIAPH1ENST00000523100.5 linkn.402+12delG intron_variant Intron 4 of 10 5 ENSP00000428208.1 B4E2I7

Frequencies

GnomAD3 genomes
AF:
0.00377
AC:
574
AN:
152076
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00513
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.00375
AC:
929
AN:
247676
AF XY:
0.00364
show subpopulations
Gnomad AFR exome
AF:
0.00156
Gnomad AMR exome
AF:
0.00757
Gnomad ASJ exome
AF:
0.000200
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.00529
Gnomad OTH exome
AF:
0.00532
GnomAD4 exome
AF:
0.00494
AC:
6923
AN:
1402608
Hom.:
35
Cov.:
25
AF XY:
0.00481
AC XY:
3371
AN XY:
700776
show subpopulations
African (AFR)
AF:
0.00105
AC:
34
AN:
32240
American (AMR)
AF:
0.00828
AC:
369
AN:
44566
Ashkenazi Jewish (ASJ)
AF:
0.000233
AC:
6
AN:
25784
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39420
South Asian (SAS)
AF:
0.000472
AC:
40
AN:
84800
European-Finnish (FIN)
AF:
0.000337
AC:
18
AN:
53344
Middle Eastern (MID)
AF:
0.00246
AC:
14
AN:
5684
European-Non Finnish (NFE)
AF:
0.00584
AC:
6180
AN:
1058332
Other (OTH)
AF:
0.00447
AC:
261
AN:
58438
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
318
637
955
1274
1592
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00377
AC:
574
AN:
152188
Hom.:
5
Cov.:
32
AF XY:
0.00372
AC XY:
277
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.000963
AC:
40
AN:
41522
American (AMR)
AF:
0.0109
AC:
167
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00513
AC:
349
AN:
68000
Other (OTH)
AF:
0.00758
AC:
16
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00404
Hom.:
1
Bravo
AF:
0.00438

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:2
May 01, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

402+12delG in intron 4 of DIAPH1: This variant is not expected to have clinical significance because it is not located within the splice consensus sequence and has been identified in 1% (74/7878) of European American chromosomes and in 0.25 % (9/3678) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu). -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nonsyndromic Hearing Loss, Mixed Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DIAPH1: BS2 -

Autosomal dominant nonsyndromic hearing loss 1;C5567650:Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.20
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.20
Position offset: 13

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs555848272; hg19: chr5-140963678; API